Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novo's Victoza REMS Settlement Opens Another Legal Door For Off-Label Promotion Cases

Sep 07 2017

• By Sue Sutter

Gavel

Related Content

Long Term Commitments: Novo Breaks New Ground with Victoza.

May 01 2010

FDA Clears Victoza, But Warnings And More Studies Pose Hurdles

Feb 01 2010

Novo Nordisk's Victoza Adds CV Benefit Claim, But Not For Primary Prevention

Aug 28 2017

Aegerion <em>Juxtapid</em> Settlement Shows REMS Have Teeth: Alternate Route To Enforce Off-Label?

May 23 2016

Novo Nordisk Settles Over US Federal Investigation Of Marketing Practices

Sep 06 2017

Related Companies

Novo Nordisk A/S

Aegerion Pharmaceuticals, Inc.

Novelion Therapeutics Inc.

Additional Topics

United States Advertising, Marketing & Sales Legal Issues Regulation Drug Safety Risk Management Metabolic Disorders BioPharmaceutical

More from Marketing & Advertising

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window